{"id":"https://openalex.org/W2012754877","doi":"https://doi.org/10.1586/14787210.5.4.573","title":"Fumagillin: an anti-infective as a parent molecule for novel angiogenesis inhibitors","display_name":"Fumagillin: an anti-infective as a parent molecule for novel angiogenesis inhibitors","publication_year":2007,"publication_date":"2007-08-01","ids":{"openalex":"https://openalex.org/W2012754877","doi":"https://doi.org/10.1586/14787210.5.4.573","mag":"2012754877","pmid":"https://pubmed.ncbi.nlm.nih.gov/17678422"},"language":"en","primary_location":{"id":"doi:10.1586/14787210.5.4.573","doi":"https://doi.org/10.1586/14787210.5.4.573","is_oa":false,"landing_page_url":"https://doi.org/10.1586/14787210.5.4.573","pdf_url":null,"source":{"id":"https://openalex.org/S185628608","display_name":"Expert Review of Anti-infective Therapy","issn_l":"1478-7210","issn":["1478-7210","1744-8336"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Anti-infective Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040722768","display_name":"Benjamin Lefkove","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benjamin Lefkove","raw_affiliation_strings":["Department of Dermatology, Emory University School of Medicine, Atlanta, GA 30322, USA. benjaminlefkove@hotmail.com","Department of Dermatology, Emory University School of Medicine, Atlanta, GA 30322, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Emory University School of Medicine, Atlanta, GA 30322, USA. benjaminlefkove@hotmail.com","institution_ids":["https://openalex.org/I150468666"]},{"raw_affiliation_string":"Department of Dermatology, Emory University School of Medicine, Atlanta, GA 30322, USA","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111542076","display_name":"Baskaran Govindarajan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Baskaran Govindarajan","raw_affiliation_strings":["Department of Dermatology, Emory University School of Medicine, 1639 Pierce Drive, Woodruff Memorial Building Room 5337, Atlanta, GA 30322, USA. bgovind@emory.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Emory University School of Medicine, 1639 Pierce Drive, Woodruff Memorial Building Room 5337, Atlanta, GA 30322, USA. bgovind@emory.edu","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004887935","display_name":"Jack L. Arbiser","orcid":"https://orcid.org/0000-0002-6798-6383","observed_orcids":["https://orcid.org/0000-0002-6798-6383"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jack L Arbiser","raw_affiliation_strings":["Department of Dermatology, Emory University School of Medicine, 1639 Pierce Drive, Woodruff Memorial Building Room 5337, Atlanta, GA 30322, USA. jarbise@emory.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Emory University School of Medicine, 1639 Pierce Drive, Woodruff Memorial Building Room 5337, Atlanta, GA 30322, USA. jarbise@emory.edu","institution_ids":["https://openalex.org/I150468666"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I150468666"],"apc_list":null,"apc_paid":null,"fwci":0.7401,"has_fulltext":false,"cited_by_count":36,"citation_normalized_percentile":{"value":0.65909597,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"5","issue":"4","first_page":"573","last_page":"579"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.5170999765396118,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.5170999765396118,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.20999999344348907,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10252","display_name":"Microbial Natural Products and Biosynthesis","score":0.07419999688863754,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fumagillin","display_name":"fumagillin","score":1.0},{"id":"https://openalex.org/keywords/angiogenesis-inhibitors","display_name":"angiogenesis inhibitors","score":0.8519999980926514},{"id":"https://openalex.org/keywords/anti-infective-agents","display_name":"anti-infective agents","score":0.8939999938011169},{"id":"https://openalex.org/keywords/aspergillus-fumigatus","display_name":"Aspergillus fumigatus","score":0.9169999957084656},{"id":"https://openalex.org/keywords/hiv","display_name":"HIV","score":0.746999979019165},{"id":"https://openalex.org/keywords/drug-synthesis","display_name":"drug synthesis","score":0.5929999947547913},{"id":"https://openalex.org/keywords/amebicides","display_name":"amebicides","score":0.6190000176429749}],"concepts":[{"id":"https://openalex.org/C2776309324","wikidata":"https://www.wikidata.org/wiki/Q120199","display_name":"Fumagillin","level":3,"score":0.9993837475776672},{"id":"https://openalex.org/C2779787849","wikidata":"https://www.wikidata.org/wiki/Q134359","display_name":"Aspergillus fumigatus","level":2,"score":0.8311829566955566},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.42346641421318054},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.41881507635116577},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.4100596010684967},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3991493284702301},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3898699879646301},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.38870346546173096},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.35610678791999817},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.12073209881782532}],"mesh":[{"descriptor_ui":"D000077609","descriptor_name":"O-(Chloroacetylcarbamoyl)fumagillol","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000626","descriptor_name":"Aminopeptidases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D000626","descriptor_name":"Aminopeptidases","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000890","descriptor_name":"Anti-Infective Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003510","descriptor_name":"Cyclohexanes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003510","descriptor_name":"Cyclohexanes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003510","descriptor_name":"Cyclohexanes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003510","descriptor_name":"Cyclohexanes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005231","descriptor_name":"Fatty Acids, Unsaturated","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005231","descriptor_name":"Fatty Acids, Unsaturated","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005231","descriptor_name":"Fatty Acids, Unsaturated","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006023","descriptor_name":"Glycoproteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D006023","descriptor_name":"Glycoproteins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012717","descriptor_name":"Sesquiterpenes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D012717","descriptor_name":"Sesquiterpenes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012717","descriptor_name":"Sesquiterpenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012717","descriptor_name":"Sesquiterpenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D063208","descriptor_name":"Methionyl Aminopeptidases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1586/14787210.5.4.573","doi":"https://doi.org/10.1586/14787210.5.4.573","is_oa":false,"landing_page_url":"https://doi.org/10.1586/14787210.5.4.573","pdf_url":null,"source":{"id":"https://openalex.org/S185628608","display_name":"Expert Review of Anti-infective Therapy","issn_l":"1478-7210","issn":["1478-7210","1744-8336"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Anti-infective Therapy","raw_type":"journal-article"},{"id":"pmid:17678422","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17678422","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert review of anti-infective therapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2657387603","display_name":null,"funder_award_id":"R01 AR02030","funder_id":"https://openalex.org/F4320337362","funder_display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases"}],"funders":[{"id":"https://openalex.org/F4320337362","display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","ror":"https://ror.org/006zn3t30"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W267359167","https://openalex.org/W1507188557","https://openalex.org/W1888373575","https://openalex.org/W1946820747","https://openalex.org/W1984587947","https://openalex.org/W2004637478","https://openalex.org/W2010435021","https://openalex.org/W2020426982","https://openalex.org/W2039565560","https://openalex.org/W2046593868","https://openalex.org/W2066778538","https://openalex.org/W2072300064","https://openalex.org/W2085785716","https://openalex.org/W2089725244","https://openalex.org/W2089920227","https://openalex.org/W2092181666","https://openalex.org/W2093996178","https://openalex.org/W2101818437","https://openalex.org/W2112431117","https://openalex.org/W2122305262","https://openalex.org/W2149960979","https://openalex.org/W2154251583","https://openalex.org/W2156562528","https://openalex.org/W4230026896","https://openalex.org/W4249091668"],"related_works":["https://openalex.org/W7096252672","https://openalex.org/W2010435021","https://openalex.org/W2950226371","https://openalex.org/W1991591242","https://openalex.org/W2414123777","https://openalex.org/W2125708506","https://openalex.org/W2034646776","https://openalex.org/W2951032229","https://openalex.org/W2952789590","https://openalex.org/W19149946"],"abstract_inverted_index":{"Fumagillin":[0,55],"is":[1,29],"an":[2,86,96],"active":[3],"amebicide":[4],"and":[5,88,98],"anti-infective":[6,25,97],"isolated":[7],"from":[8],"the":[9,36,43,47,71,77],"fungus":[10],"Aspergillus":[11],"fumigatus.":[12],"Since":[13],"its":[14,24,64],"characterization":[15],"in":[16,35,52],"1951,":[17],"fumagillin":[18,28],"has":[19,40],"been":[20],"studied":[21],"extensively":[22],"for":[23,32,46],"properties.":[26],"Although":[27],"not":[30],"approved":[31],"systemic":[33],"use":[34],"USA,":[37],"this":[38,83,92],"compound":[39],"one":[41],"of":[42,49,74,79,82,91],"highest":[44],"efficacies":[45],"treatment":[48],"microsporidial":[50],"infections":[51],"HIV-positive":[53],"patients.":[54],"does":[56],"exhibit":[57],"some":[58],"side":[59],"effects":[60],"that":[61],"have":[62],"deterred":[63],"acceptance":[65],"as":[66,94],"a":[67],"viable":[68],"treatment,":[69],"but":[70],"current":[72],"body":[73],"research":[75],"on":[76],"synthesis":[78],"novel":[80],"analogs":[81],"molecule":[84],"shows":[85],"exciting":[87],"promising":[89],"revival":[90],"drug":[93],"both":[95],"antiangiogenic":[99],"agent.":[100]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}